{
  "id": "NGN_Bowtie_AKI_BATCH-300-81-1771347159674",
  "itemType": "bowtie",
  "cjjmStep": "Generate Solutions",
  "difficulty": 4,
  "questionSource": "internal",
  "topic": "AKI Management",
  "scenarioSeed": "BATCH-300-81-1771347159674",
  "stem": "The nurse is caring for a 68-year-old male client. Based on the client's assessment and laboratory findings, complete the bowtie by selecting the most likely condition the client is experiencing, two actions the nurse should take, and two parameters the nurse should monitor.",
  "case": {
    "sbar": {
      "situation": "0700: 68-year-old male admitted from the emergency department with increasing fatigue, swelling in his legs, and shortness of breath over the past three days.",
      "background": "History of hypertension and osteoarthritis. Reports taking high-dose ibuprofen for knee pain for the last two weeks. Urine output has significantly decreased.",
      "assessment": "0715: BP 172/98 mmHg, HR 102 bpm, RR 22 breaths/min, Temp 37.1°C (98.8°F), SpO2 93% on room air. Alert and oriented x3, appears anxious. Lungs with bibasilar crackles. Heart sounds are regular with an audible S3 gallop. Abdomen is soft, non-distended. Exhibits 2+ pitting edema in bilateral lower extremities. Urine output has been 15 mL/hr for the past 4 hours. Serum Creatinine: 3.8 mg/dL (Baseline 3 months ago: 1.1 mg/dL), BUN: 45 mg/dL, Serum Potassium: 5.8 mEq/L, Serum Sodium: 132 mEq/L, eGFR: 15 mL/min/1.73m².",
      "recommendation": "The client is experiencing Acute Kidney Injury (AKI). Recommend administering IV furosemide as prescribed and implementing continuous cardiac monitoring. Closely monitor urine output and serum potassium level."
    },
    "intro": "A 68-year-old male with a history of hypertension and osteoarthritis is admitted from the emergency department with increasing fatigue, swelling in his legs, and shortness of breath over the past three days. He reports taking high-dose ibuprofen for knee pain for the last two weeks. He states his urine output has significantly decreased.",
    "tabs": [
      {
        "id": "vitals",
        "label": "Vital Signs",
        "content": "Blood Pressure: 172/98 mmHg\nHeart Rate: 102 bpm\nRespiratory Rate: 22 breaths/min\nTemperature: 37.1°C (98.8°F)\nSpO2: 93% on room air"
      },
      {
        "id": "assessment",
        "label": "Nurse's Notes",
        "content": "Client is alert and oriented x3, appears anxious. Lungs with bibasilar crackles. Heart sounds are regular with an audible S3 gallop. Abdomen is soft, non-distended. Exhibits 2+ pitting edema in bilateral lower extremities. Urine output has been 15 mL/hr for the past 4 hours."
      },
      {
        "id": "labs",
        "label": "Laboratory Results",
        "content": "Serum Creatinine: 3.8 mg/dL (0.7-1.3 mg/dL)\n*Baseline creatinine 3 months ago: 1.1 mg/dL*\nBlood Urea Nitrogen (BUN): 45 mg/dL (10-20 mg/dL)\nSerum Potassium: 5.8 mEq/L (3.5-5.0 mEq/L)\nSerum Sodium: 132 mEq/L (136-145 mEq/L)\neGFR: 15 mL/min/1.73m² (>60 mL/min/1.73m²)"
      }
    ]
  },
  "options": {
    "actions": [
      {
        "id": "A1",
        "text": "Administer IV furosemide as prescribed"
      },
      {
        "id": "A2",
        "text": "Administer a 1 L bolus of 0.9% sodium chloride"
      },
      {
        "id": "A3",
        "text": "Implement continuous cardiac monitoring"
      },
      {
        "id": "A4",
        "text": "Encourage increased oral fluid intake"
      },
      {
        "id": "A5",
        "text": "Administer spironolactone as prescribed"
      }
    ],
    "condition": [
      {
        "id": "C1",
        "text": "Heart Failure Exacerbation"
      },
      {
        "id": "C2",
        "text": "Acute Kidney Injury (AKI)"
      },
      {
        "id": "C3",
        "text": "Chronic Kidney Disease (CKD)"
      },
      {
        "id": "C4",
        "text": "Nephrotic Syndrome"
      },
      {
        "id": "C5",
        "text": "Hypertensive Crisis"
      }
    ],
    "parameters": [
      {
        "id": "P1",
        "text": "Urine output"
      },
      {
        "id": "P2",
        "text": "Blood glucose level"
      },
      {
        "id": "P3",
        "text": "White blood cell count"
      },
      {
        "id": "P4",
        "text": "Serum potassium level"
      },
      {
        "id": "P5",
        "text": "Pain level"
      }
    ]
  },
  "correctAnswer": {
    "actions": [
      "A1",
      "A3"
    ],
    "condition": "C2",
    "parameters": [
      "P1",
      "P4"
    ]
  },
  "answerBreakdown": {
    "condition": {
      "C1": "Incorrect. (-)\nRationale: While the client exhibits signs of fluid overload (edema, crackles) suggestive of heart failure, the primary issue is the acute decline in kidney function. The rapid increase in creatinine from baseline (1.1 to 3.8 mg/dL) and NSAID use strongly indicate a kidney-related problem, making AKI the more accurate diagnosis. Heart failure can contribute to AKI (cardiorenal syndrome), but the primary insult is to the kidneys.\n\nPathophysiology: AKI can lead to fluid retention, increasing preload and potentially exacerbating heart failure symptoms. However, treating the AKI is paramount to improving overall hemodynamics.\n",
      "C2": "Correct. (+)\nRationale: The client's presentation is consistent with AKI. Key indicators include recent high-dose NSAID use (a common cause of pre-renal AKI), a rapid increase in serum creatinine and BUN, oliguria (15 mL/hr), low eGFR, and signs of fluid overload and electrolyte imbalance (hyperkalemia, hyponatremia).\n\nPathophysiology: NSAIDs inhibit prostaglandin synthesis, leading to afferent arteriolar vasoconstriction in the kidneys, reducing renal blood flow and GFR. This can cause pre-renal AKI. The kidneys' inability to filter waste products leads to elevated creatinine and BUN. Oliguria results from decreased glomerular filtration. Hyperkalemia occurs due to impaired potassium excretion.\n",
      "C3": "Incorrect. (-)\nRationale: Chronic Kidney Disease (CKD) is a progressive loss of kidney function over months or years. This client's creatinine has risen sharply from a normal baseline just three months ago, indicating an acute, not chronic, process. While underlying CKD could predispose to AKI, the acute presentation points to AKI as the primary diagnosis.\n\nPathophysiology: CKD involves gradual nephron damage and loss of function. AKI is a sudden insult that further compromises kidney function.\n",
      "C4": "Incorrect. (-)\nRationale: Nephrotic syndrome is characterized by massive proteinuria, hypoalbuminemia, and edema. While edema is present, there is no information about proteinuria, and the primary lab abnormalities are elevated creatinine and potassium, which are more indicative of AKI. The absence of reported proteinuria makes nephrotic syndrome less likely.\n\nPathophysiology: Nephrotic syndrome results from glomerular damage, leading to protein leakage into the urine. This causes hypoalbuminemia and subsequent edema due to decreased oncotic pressure.\n",
      "C5": "Incorrect. (-)\nRationale: The client is hypertensive (172/98 mmHg), but this is likely a consequence of the fluid overload caused by AKI rather than the primary condition. A hypertensive crisis typically involves a BP >180/120 mmHg with evidence of end-organ damage, and while AKI is a form of end-organ damage, it is the central problem here. The hypertension is secondary to the AKI.\n\nPathophysiology: Fluid retention in AKI increases blood volume, leading to hypertension. A hypertensive crisis involves severe hypertension causing acute end-organ damage.\n"
    },
    "actions": {
      "A1": "Correct. (+)\nRationale: The client is hypervolemic (fluid overloaded) as evidenced by bibasilar crackles, pitting edema, and hypertension. A loop diuretic like furosemide is essential to promote diuresis, remove excess fluid, and help lower the elevated potassium level.\n\nPathophysiology: Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting water excretion and reducing fluid overload. This also helps to excrete potassium.\n",
      "A2": "Incorrect. (-)\nRationale: Administering a fluid bolus is contraindicated. This action would be appropriate for pre-renal AKI caused by hypovolemia. However, this client is clearly hypervolemic, and additional fluids would worsen the pulmonary edema and hypertension, potentially leading to respiratory failure.\n\nPathophysiology: Adding more fluid to an already overloaded system increases hydrostatic pressure, exacerbating edema and pulmonary congestion.\n",
      "A3": "Correct. (+)\nRationale: The serum potassium is 5.8 mEq/L (hyperkalemia), which poses a significant and immediate risk for life-threatening cardiac dysrhythmias, such as ventricular tachycardia or fibrillation. Continuous cardiac monitoring is crucial to detect any ECG changes (e.g., peaked T waves, widened QRS) and intervene promptly.\n\nPathophysiology: Hyperkalemia affects myocardial cell excitability, leading to altered repolarization and potentially fatal arrhythmias.\n",
      "A4": "Incorrect. (-)\nRationale: Encouraging oral fluid intake would exacerbate the client's fluid overload. A fluid restriction is the appropriate intervention to manage hypervolemia in a client with AKI and oliguria.\n\nPathophysiology: Increasing fluid intake in the setting of impaired kidney function worsens fluid retention and associated complications.\n",
      "A5": "Incorrect. (-)\nRationale: Spironolactone is a potassium-sparing diuretic. Administering this medication to a client who is already hyperkalemic (K+ 5.8 mEq/L) is extremely dangerous and could lead to severe, life-threatening hyperkalemia and cardiac arrest.\n\nPathophysiology: Spironolactone blocks aldosterone, leading to sodium and water excretion but potassium retention. This would worsen hyperkalemia.\n"
    },
    "parameters": {
      "P1": "Correct. (+)\nRationale: Monitoring urine output is a critical parameter to assess kidney function and the client's response to interventions like diuretics. An increase in urine output would indicate improving renal perfusion and function.\n\nPathophysiology: Urine output reflects glomerular filtration rate and tubular function. Changes in urine output indicate changes in kidney function.\n",
      "P2": "Incorrect. (-)\nRationale: While blood glucose is a standard parameter to monitor in hospitalized patients, there is no indication in the client's history or presentation that they have diabetes or are at immediate risk for glycemic instability. It is not a priority compared to parameters directly related to the AKI.\n\nPathophysiology: Blood glucose monitoring is essential for diabetic patients or those at risk for hyperglycemia/hypoglycemia. It is not directly related to AKI unless the AKI is caused by diabetic nephropathy (not indicated here).\n",
      "P3": "Incorrect. (-)\nRationale: The client has no signs or symptoms of infection (e.g., fever, localized pain, elevated temperature). Therefore, monitoring the white blood cell count is not a priority in managing this client's acute problem.\n\nPathophysiology: WBC count is an indicator of infection or inflammation. It is not directly related to AKI unless the AKI is caused by sepsis.\n",
      "P4": "Correct. (+)\nRationale: Hyperkalemia (K+ 5.8 mEq/L) is a life-threatening complication of AKI. The serum potassium level must be monitored closely to evaluate the effectiveness of treatments (e.g., diuretics, potassium-lowering agents) and to prevent cardiac arrest.\n\nPathophysiology: Impaired potassium excretion in AKI leads to hyperkalemia, which can cause cardiac arrhythmias and arrest.\n",
      "P5": "Incorrect. (-)\nRationale: The client has a history of osteoarthritis and was taking ibuprofen for knee pain, but pain is not the acute, life-threatening problem. The immediate priorities are managing the fluid overload, electrolyte imbalances, and impaired kidney function.\n\nPathophysiology: While pain management is important, it is not the priority in this acute situation. Addressing the AKI and its complications is paramount.\n"
    }
  },
  "clinicalPearls": [
    "NSAIDs can cause acute kidney injury, especially in patients with underlying risk factors such as hypertension or pre-existing kidney disease.",
    "Hyperkalemia is a life-threatening complication of AKI and requires prompt recognition and treatment. ECG changes are the earliest signs.",
    "Fluid overload in AKI can lead to pulmonary edema and respiratory distress, necessitating careful fluid management. Fluid restriction is often necessary."
  ],
  "sentinelStatus": "healed_v2026_v8"
}